Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition
- 31 March 1995
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 59 (3) , 598-603
- https://doi.org/10.1016/0003-4975(94)00919-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cardiac-derived thromboxane A2The Journal of Thoracic and Cardiovascular Surgery, 1993
- Cardiopulmonary bypass and pulmonary thromboxane generationThe Annals of Thoracic Surgery, 1993
- Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1.Circulation Research, 1991
- Thromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia.Circulation Research, 1989
- Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in catsAmerican Heart Journal, 1989
- Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.Circulation Research, 1988
- Eicosanoids and the blood vessel wall.Circulation, 1984
- The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.Circulation, 1983